Cardinal Partners is a venture capital firm with extensive experience in starting, incubating, and investing in early-stage healthcare technology-enabled services and life sciences companies. The firm has been delivering top quartile returns since its inception in 1996.
1996
Privately held
Focus on early and growth-stage investments in disruptive technologies, indicating a higher risk tolerance with potential for high rewards.
Princeton, Nj, United States
About
Mission
We aim to engineer the flow of healthcare by leveraging technology to enhance accessibility and efficiency.
Values
Financial discipline, capital efficiency, hands-on collaboration, and innovation in healthcare.
Participant Demographics
Investors include university endowments, foundations, pension funds, banks, and insurance companies.
Track Record
Team Experience
Extensive experience in early and growth-stage healthcare investments, with a history of more than 25 IPOs.
Notable Achievements
Companies funded by Cardinal Partners have achieved a cumulative market valuation exceeding $15 billion.
Project Track Record
Investments in notable companies such as Cubist Pharmaceuticals (acquired by Merck for $8.4 billion) and Sapphire Digital (acquired by Zelis in 2021).
Get Full Profile
Access complete investment history, team details, portfolio companies, and direct contact information.
Unlock Full AccessHeadquarters
Princeton, Nj, United States
Access 150,000+ investor profiles
Get complete access to our database of investment firms with detailed profiles, contact information, investment preferences, and AI-powered matching.